Third Bench Inc (THBD): And then reverse split again. And I get...

bri123 · 2025-02-26T16:51:30.9170000Z

And then reverse split again. And I get screwed again. Wonderful.

Play Episode

6min

Proactive - Interviews for investors

Switch Metals eyes fast-track tantalum output in Côte d'Ivoire as it lists on AIM

Switch Metals Plc (AIM:SWT) CEO Karl Akueson talked with Proactive's Stephen Gunnion about the company’s listing on London’s AIM market and its focus on developing tantalum projects in Côte d'Ivoire. Akueson explained that Switch Metals, a private company he founded, was acquired through a reverse takeover by Oneiro Energy. The company's flagship Issia project hosts tantalum mineralisation, including occurrences of coltan at surface. According to Akueson, this provides an opportunity for near-term production from shallow deposits, with the company aiming to reach output within the next two years. He described tantalum as “a very strategic technology metal… in our mobile phones, laptops, plasma TV, everything we use daily,” highlighting its importance and rarity. Akueson emphasised that 60% of the global supply currently comes from the DRC and Rwanda, and Switch Metals aims to become a significant alternative source. Discussing the decision to list in the UK, Akueson pointed to his personal background and the UK’s long-standing understanding of African production. The £2 million fundraise will support resource definition work at Issia, with plans to quickly define a resource and develop economic parameters to demonstrate value. “Tantalum is probably one of the most critical [metals], and a metal that is unique,” Akueson noted. For more interviews and updates, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and enable notifications for future content. #Tantalum #SwitchMetals #CotedIvoireMining #CriticalMinerals #AIMListing #JuniorMining #ResourceDefinition #Coltan #TechMetals #ProactiveInvestors

Proactive - Interviews for investors

Arc Minerals expands portfolio with acquisition of Chingola Copper Project in Zambia

Arc Minerals Limited (AIM:ARCM) executive chairman Nick von Schirnding and chief operating officer Vassilios Carellas joined Stephen Gunnion in the Proactive studio with details of the company’s latest acquisition—the Chingola Copper Project in Zambia. Von Schirnding highlighted that the project is located in the northeast of the Zambian Copper Belt, an area known for high-grade copper deposits. The site is less than 30km from major existing operations, including Vedanta’s Nchanga Mine and Moxico Resources’ Mimbula Mine. He described the acquisition as strategic, adding that Arc Minerals has been pursuing it for 18 months due to its high prospectivity. Carellas detailed the financial terms of the deal, explaining that Arc Minerals has committed an initial $75,000, with milestone-based payments tied to drilling and resource confirmation. He emphasised that the transaction is structured to limit financial risk, allowing the company to exit if exploration does not yield the expected results. Von Schirnding also reassured investors that the company’s upcoming exploration work at Chingola is fully funded, with soil sampling expected to commence soon. The project will add to Arc Minerals’ growing portfolio, which includes its joint venture with Anglo American in Zambia’s northwest and assets in Botswana. Carellas noted that Chingola’s geological potential remains largely untested in the last 20 years, making it a prime target for new exploration techniques. The company expects active news flow as soil sampling and drilling programs progress. Arc Minerals also provided updates on its joint venture with Anglo American, confirming that preparations are underway for drilling to commence soon. Stay tuned for more updates on Arc Minerals’ progress. Don’t forget to like this video, subscribe to Proactive’s YouTube channel, and turn on notifications for the latest updates on mining and investment news. #ArcMinerals #CopperMining #Zambia #MiningInvestment #ChingolaProject #

Proactive - Interviews for investors

Zynex Medical champions noninvasive, non-addictive pain management with NexWave

Zynex Medical Executive Vice President of Sales Steve Fox joined Steve Darling from Proactive to discuss the company’s commitment to noninvasive, non-addictive at-home pain management through its flagship device, NexWave. Fox highlighted how Zynex Medical is tackling the opioid crisis by providing alternative pain solutions that empower both healthcare providers and patients. The NexWave device integrates three key modalities—TENS (Transcutaneous Electrical Nerve Stimulation), IFC (Interferential Current), and NMES (Neuromuscular Electrical Stimulation)—making it a versatile tool for post-operative recovery and long-term pain management. “Most providers are really on board with a device like this because it’s very universal,” Fox explained. A crucial aspect of Zynex’s strategy is education, with nearly 300 sales representatives across the U.S. working to inform healthcare providers about alternatives to opioid prescriptions. While the company’s focus remains on the domestic market, Fox noted significant untapped potential within the United States. Fox also spoke about Zynex’s strong internal culture, emphasizing the team’s alignment around a shared mission. “It’s our mission to provide an at-home pain management treatment option that’s noninvasive, non-addictive. That won’t change,” he said, highlighting the passion and unity that continue to drive the company’s growth. #proactiveinvestors #nasdaq #zyxi #zynexinc #NexWave #PainManagement #OpioidAlternative #MedicalDevices #NonInvasiveTherapy #NMES #TENS #HealthcareInnovation #ProactiveInvestors

Proactive - Interviews for investors

NanoViricides highlights broad-spectrum antiviral strategy and progress with lead drug candidate

NanoViricides Chief Financial Officer Meeta Vyas joined Steve Darling from Proactive to share updates on the company’s development of broad-spectrum antiviral therapeutics and its unique positioning amid global market uncertainty. Vyas emphasized that NanoViricides, headquartered in Shelton, Connecticut, conducts all of its research and development in-house, which insulates the company from international tariff fluctuations and supply chain disruptions. At the center of the company’s pipeline is NV-387, a broad-spectrum antiviral drug that differs from vaccines in both function and strategy. Rather than targeting specific viral strains, NV-387 works by mimicking the receptor sites used by over 90% of pathogenic viruses—including influenza, RSV, COVID-19, and smallpox. Vyas explained that this approach helps circumvent the problem of viral mutation, which often renders traditional vaccines less effective. “Regardless of how they mutate, they land on the same receptor site. So we copy the receptor site, which is invariant to mutation,” she said, underscoring the robustness of the NanoViricides platform. She also highlighted supportive regulatory developments in the U.S., noting that the new HHS administration has endorsed a more integrated approach to pandemic preparedness, which includes therapeutics like NV-387 as a key component. In light of recent USDA funding initiatives aimed at combating H5N1 avian flu, Vyas said the company is keen to explore applications of NV-387 in that space as well. Currently, NanoViricides is conducting a Phase 2 clinical trial targeting smallpox, following successful Phase 1 results with no reported adverse effects. #proactiveinvestors #nanoviricidesinc #nyseamerican #nnvc NV387 #BroadSpectrumAntiviral #BiotechStocks #AntiviralTherapeutics #SmallpoxTreatment #BirdFlu #RSV #COVID19Treatment #ProactiveInvestors #PharmaInnovation #MeetaVyas #HHS #PandemicPreparedness

Followers	12
Posts	2692
Boards Moderated	4
Alias Born	03/17/2014

Volume:	6,460,981
Day Range:	0.000001 - 0.0001
Bid:	0.0001
Ask:	0.0002
Last Trade Time:	3:06:27 PM EDT
Total Trades:	12

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

THBD Detailed Quote

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Go Ad-Free